References
Rainsford KD. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions. Rheumatology 1999; 38(suppl.1):4–10
Boelsterli UA. Nimesulide and hepatic adverse effects: roles of reactive metabolites and host factors. Int J Clin Pract Suppl 2002; 128:30–6
Conforti A, Leone R, Moretti Ugo, et al. Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on Nimesulide: Results of Spontaneous Reporting from a Northern Italian Area. Drug Safety 2001; 24(14):1081–90
Summary of Product Characteristics: — Nimesulide 100mg Tablet, http://www.emea.eu.int/pdfs/human/referral/nimesulide/308603en.pdf.CPMP/3086/03-REV.1EMEA 2004.
Rabasseda X. Safety profile of Nimesulide: ten years of clinical experience. Drugs of Today Vol.33 Suppl.I, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, M., Chatterjee, A., Gupta, S.K. et al. Safety Profile of Extended Release Formulation of Nimesulide in Asian Indian Population: A Prescription Event Monitoring Programme. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200831100-00029